[Skip to Navigation]
Editor's Note
July 8, 2019

Industry Payments and Physician Prescribing

Author Affiliations
  • 1Editor at Large, JAMA Internal Medicine
JAMA Intern Med. 2019;179(10):1428-1429. doi:10.1001/jamainternmed.2019.1081

The Open Payments database at the Centers for Medicare & Medicaid Services continues to shine a bright light on the association between industry payments to physicians by drug and medical device companies and prescribing. In this issue of JAMA Internal Medicine, 2 Research Letters examine the association between these payments and physician prescribing in diverse fields—biologic medications for inflammatory bowel diseases1 and gabapentinoids for various conditions, including seizure disorders and postherpetic neuralgia.2

Add or change institution